Drug Trial Radar · NCT01047501
Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)
Last checked: Nov 19, 2026Latest source record: Apr 25, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
702
Actual
Start
Dec 2009
Primary completion
Feb 2011
Study completion Feb 2011
Sponsor
- Lead sponsor
- Amarin Pharma Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 13, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective is to determine the efficacy of AMR101 (ethyl icosapentate) compared to placebo in lowering high fasting triglyceride levels in patients with high risk for cardiovascular disease and fasting triglyceride levels ≥ 200 and \< 500 mg/dL.
Conditions
- Hypertriglyceridemia
Interventions
AMR101 (ethyl icosapentate) - 4 g/dayDrug
AMR101 (ethyl icosapentate) 4 capsules/day for 12 weeks
AMR101 (ethyl icosapentate) - 2 g/dayDrug
AMR101 (ethyl icosapentate) 2 capsules/day with placebo 2 capsules/day for 12 weeks
PlaceboDrug
Placebo 4 capsules/day for 12 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Difference Between AMR101 (Ethyl Icosapentate) and Placebo Treatment Groups in Triglyceride Lowering EffectTime frame: baseline and 12 weeks
Locations
80 sites in 1 country. Site status is shown where the registry gives one.
Amarin Investigational Site
Muscle Shoals, Alabama
Amarin Investigational Site
Scottsboro, Alabama
Amarin Investigational Site
Phoenix, Arizona
Amarin Investigational Site
Tucson, Arizona
Amarin Investigational Site
Anaheim, California
Amarin Investigational Site
Burbank, California
Amarin Investigational Site
Chino, California
Amarin Investigational Site
Encinitas, California
Amarin Investigational Site
Irvine, California
Amarin Investigational Site
Los Angeles, California
Amarin Investigational Site
Los Angeles, California
Amarin Investigational Site
Spring Valley, California
Amarin Investigational Site
Westlake Village, California
Amarin Investigational Site
Golden, Colorado
Amarin Investigational Site
Wheat Ridge, Colorado
Amarin Investigational Site
Aventura, Florida
Amarin Investigational Site
Clearwater, Florida
Amarin Investigational Site
Coral Gables, Florida
Amarin Investigational Site
Hialeah, Florida
Amarin Investigational Site
Jacksonville, Florida
Amarin Investigational Site
Jacksonville, Florida
Amarin Investigational Site
Miami, Florida
Amarin Investigational Site
New Port Richey, Florida
Amarin Investigational Site
New Port Richey, Florida
Amarin Investigational Site
Orlando, Florida
Amarin Investigational Site
Port Orange, Florida
Amarin Investigational Site
West Palm Beach, Florida
Amarin Investigational Site
Augusta, Georgia
Amarin Investigational Site
Augusta, Georgia
Amarin Investigational Site
Addison, Illinois
Amarin Investigational Site
Morton, Illinois
Amarin Investigational Site
Indianapolis, Indiana
Amarin Investigational Site
Kansas City, Kansas
Amarin Investigational Site
Newton, Kansas
Amarin Investigational Site
Wichita, Kansas
Amarin Investigational Site
Louisville, Kentucky
Amarin Investigational Site
Munfordville, Kentucky
Amarin Investigational Site
Auburn, Maine
Amarin Investigational Site
Baltimore, Maryland
Amarin Investigational Site
Elkridge, Maryland
Showing 40 of 80 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.